{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:05:38Z","timestamp":1790849138106,"version":"4.1.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00422","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T15:36:54Z","timestamp":1584718614000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications"],"prefix":"10.3389","volume":"11","author":[{"given":"Giuseppe","family":"Lia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Di Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cerrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Brunello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Calcaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tapparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Mavilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"B1","unstructured":"D'SouzaA\n            FrethamC\n          Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fimmu.2017.00496","article-title":"Graft-vs. -leukemia effect following hematopoietic stem cell transplantation for leukemia","volume":"8","author":"Dickinson","year":"2017","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1158\/0008-5472.CAN-16-1311","article-title":"Allogeneic stem cell transplantation: a historical and scientific overview","volume":"76","author":"Singh","year":"2016","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: a retrospective observational study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"Lancet Haematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-vs. -host disease as measured by NIH criteria: report on baseline data from the chronic GVHD consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-vs. -host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus development project on criteria for clinical trials in chronic graft-vs. -host disease: I The Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-vs. -host disease \u2014 biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1084\/jem.183.6.2645","article-title":"The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice","volume":"183","author":"Baker","year":"1996","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/bjh.16190","article-title":"Advances in understanding the pathogenesis of graft-vs. -host disease","volume":"187","author":"Zeiser","year":"2019","journal-title":"Br J Haematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-vs. -host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41409-018-0214-5","article-title":"Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies","volume":"54","author":"Sureda","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S1470-2045(18)30580-1","article-title":"Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial","volume":"19","author":"Platzbecker","year":"2018","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3324\/haematol.2017.168716","article-title":"Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of B","volume":"103","author":"Schmid","year":"2018","journal-title":"Haematologica"},{"key":"B16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tcb.2016.11.003","article-title":"Extracellular vesicles: unique intercellular delivery vehicles","volume":"27","author":"Maas","year":"2017","journal-title":"Trends Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra1704286","article-title":"Circulating extracellular vesicles in human disease","volume":"379","author":"Shah","year":"2018","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s12276-019-0223-5","article-title":"Extracellular vesicle-based therapeutics: natural vs. engineered targeting and trafficking","volume":"51","author":"Murphy","year":"2019","journal-title":"Exp Mol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e3000363","DOI":"10.1371\/journal.pbio.3000363","article-title":"The biology of extracellular vesicles: the known unknowns","volume":"17","author":"Margolis","year":"2019","journal-title":"PLoS Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"15503","DOI":"10.1038\/s41598-018-33899-6","article-title":"Small non-coding RNA landscape of extracellular vesicles from human stem cells","volume":"8","author":"Kaur","year":"2018","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13287-015-0116-z","article-title":"Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species","volume":"6","author":"Baglio","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R435","DOI":"10.1016\/j.cub.2018.01.059","article-title":"Exosomes and ectosomes in intercellular communication","volume":"28","author":"Meldolesi","year":"2018","journal-title":"Curr Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fimmu.2018.00534","article-title":"Extracellular vesicle subtypes released from activated or apoptotic t-lymphocytes carry a specific and stimulus-dependent protein cargo","volume":"9","author":"Tucher","year":"2018","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1461450","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-017-0160-y","article-title":"Preservation and storage stability of extracellular vesicles for therapeutic applications","volume":"20","author":"Jeyaram","year":"2018","journal-title":"AAPS J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"19861","DOI":"10.3402\/jev.v2i0.19861","article-title":"How pure are your vesicles?","volume":"2","author":"Webber","year":"2013","journal-title":"J Extracell Vesicles"},{"key":"B27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0022-1759(02)00330-7","article-title":"Production and characterization of clinical grade exosomes derived from dendritic cells","volume":"270","author":"Lamparski","year":"2002","journal-title":"J Immunol Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23430","DOI":"10.3402\/jev.v3.23430","article-title":"Single-step isolation of extracellular vesicles by size-exclusion chromatography","volume":"3","author":"B\u00f6ing","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1800528","DOI":"10.1002\/biot.201800528","article-title":"Scalable production and isolation of extracellular vesicles: available sources and lessons from current industrial bioprocesses","volume":"14","author":"Paganini","year":"2019","journal-title":"Biotechnol J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of exosome composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.3390\/s18103175","article-title":"Lab-on-Chip for exosomes and microvesicles detection and characterization","volume":"18","author":"Chiriac\u00f2","year":"2018","journal-title":"Sensors"},{"key":"B32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/cells8040307","article-title":"Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes","volume":"8","author":"Gurunathan","year":"2019","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jth.13514","article-title":"Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop","volume":"15","author":"Cointe","year":"2017","journal-title":"J Thromb Haemost"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2217\/nnm.12.173","article-title":"Quantification of nanosized extracellular membrane vesicles with scanning ion occlusion sensing","volume":"8","author":"de Vrij","year":"2013","journal-title":"Nanomedicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12015-011-9228-8","article-title":"Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation","volume":"7","author":"Pontikoglou","year":"2011","journal-title":"Stem Cell Rev Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.15171\/apb.2017.065","article-title":"The effect of mesenchymal stem cell-derived extracellular vesicles on hematopoietic stem cells fate","volume":"7","author":"Timari","year":"2017","journal-title":"Adv Pharm Bull"},{"key":"B38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.15171\/apb.2015.042","article-title":"The impact of mesenchymal stem cells on differentiation of hematopoietic stem cells","volume":"5","author":"Saleh","year":"2015","journal-title":"Adv Pharm Bull"},{"key":"B39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jcyt.2014.11.011","article-title":"Hematopoietic recovery of acute radiation syndrome by human superoxide dismutase\u2013expressing umbilical cord mesenchymal stromal cells","volume":"17","author":"Gan","year":"2015","journal-title":"Cytotherapy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.exphem.2013.01.002","article-title":"Mitigating effects of hUCB-MSCs on the hematopoietic syndrome resulting from total body irradiation","volume":"41","author":"Shim","year":"2013","journal-title":"Exp Hematol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"353878","DOI":"10.1155\/2011\/353878","article-title":"Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche","volume":"2011","author":"Li","year":"2011","journal-title":"Bone Marrow Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6493241","DOI":"10.1155\/2016\/6493241","article-title":"Mesenchymal stem cell-derived microvesicles support ex vivo expansion of cord blood-derived CD34 + cells","volume":"2016","author":"Xie","year":"2016","journal-title":"Stem Cells Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3324\/haematol.2009.010736","article-title":"Hematopoietic stem cells in co-culture with mesenchymal stromal cells - modeling the niche compartments in vitro","volume":"95","author":"Jing","year":"2010","journal-title":"Haematologica"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell Death Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.21037\/sci.2017.09.06","article-title":"Clinical potential of mesenchymal stem\/stromal cell-derived extracellular vesicles","volume":"4","author":"Giebel","year":"2017","journal-title":"Stem Cell Investig"},{"key":"B47","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fimmu.2019.00446","article-title":"Extracellular vesicles mediate mesenchymal stromal cell-dependent regulation of B cell PI3K-AKT signaling pathway and actin cytoskeleton","volume":"10","author":"Adamo","year":"2019","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.imlet.2012.06.001","article-title":"Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling","volume":"147","author":"Mokarizadeh","year":"2012","journal-title":"Immunol Lett"},{"key":"B49","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2015.08.018","article-title":"MSC transplantation improves osteopenia via epigenetic regulation of notch signaling in lupus","volume":"22","author":"Liu","year":"2015","journal-title":"Cell Metab"},{"key":"B50","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-vs. -host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1089\/scd.2016.0107","article-title":"Extracellular vesicles released from human umbilical cord-derived mesenchymal stromal cells prevent life-threatening acute graft-vs. -host disease in a mouse model of allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Wang","year":"2016","journal-title":"Stem Cells Dev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-018-0680-7","article-title":"A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD","volume":"11","author":"Lai","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells Dev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jconrel.2016.07.044","article-title":"Mesenchymal stem cell and derived exosome as small RNA carrier and immunomodulator to improve islet transplantation","volume":"238","author":"Wen","year":"2016","journal-title":"J Control Release"},{"key":"B55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41232-016-0030-5","article-title":"Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model","volume":"36","author":"Tamura","year":"2016","journal-title":"Inflamm Regen"},{"key":"B56","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fimmu.2014.00556","article-title":"Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells","volume":"5","author":"Blazquez","year":"2014","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"21927","DOI":"10.3402\/jev.v2i0.21927","article-title":"Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning","volume":"2","author":"Kilpinen","year":"2013","journal-title":"J Extracell Vesicles"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3727\/096368915X687543","article-title":"Immunoregulatory effects of mesenchymal stem cell-derived extracellular vesicles on T lymphocytes","volume":"24","author":"Del Fattore","year":"2015","journal-title":"Cell Transplant"},{"key":"B59","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s12026-016-8798-6","article-title":"Immunomodulatory effects of mesenchymal stromal cells-derived exosome","volume":"64","author":"Chen","year":"2016","journal-title":"Immunol Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s00125-014-3262-4","article-title":"Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes","volume":"57","author":"Favaro","year":"2014","journal-title":"Diabetologia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/mt.2015.67","article-title":"Mesenchymal stromal cells derived from crohn's patients deploy indoleamine 2,3-dioxygenase-mediated immune suppression, independent of autophagy","volume":"23","author":"Chinnadurai","year":"2015","journal-title":"Mol Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3727\/096368911X582769b","article-title":"The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles","volume":"22","author":"Budoni","year":"2013","journal-title":"Cell Transplant"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1089\/scd.2014.0091","article-title":"Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro","volume":"23","author":"Conforti","year":"2014","journal-title":"Stem Cells Dev"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1089\/scd.2014.0563","article-title":"Extracellular vesicles secreted by bone marrow- and adipose tissue-derived mesenchymal stromal cells fail to suppress lymphocyte proliferation","volume":"24","author":"Gouveia de Andrade","year":"2015","journal-title":"Stem Cells Dev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/ijms20071642","article-title":"Individual immune-modulatory capabilities of MSC-derived extracellular vesicle (EV) preparations and recipient-dependent responsiveness","volume":"20","author":"Kordelas","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/stem.2730","article-title":"Inflammation-stimulated mesenchymal stromal cell-derived extracellular vesicles attenuate inflammation","volume":"36","author":"Harting","year":"2018","journal-title":"Stem Cells"},{"key":"B68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/carcin\/bgn234","article-title":"Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds","volume":"30","author":"Tasso","year":"2009","journal-title":"Carcinogenesis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(high) forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12967-015-0642-6","article-title":"LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b","volume":"13","author":"Ti","year":"2015","journal-title":"J Transl Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ebiom.2016.04.030","article-title":"Exosome derived from human umbilical cord mesenchymal stem cell mediates MiR-181c attenuating burn-induced excessive inflammation","volume":"8","author":"Li","year":"2016","journal-title":"EBioMedicine"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0190358","DOI":"10.1371\/journal.pone.0190358","article-title":"Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord","volume":"13","author":"Lankford","year":"2018","journal-title":"PLoS ONE"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1240301","DOI":"10.1155\/2016\/1240301","article-title":"CCR2 positive exosome released by mesenchymal stem cells suppresses macrophage functions and alleviates ischemia\/reperfusion-induced renal injury","volume":"2016","author":"Shen","year":"2016","journal-title":"Stem Cells Int"},{"key":"B74","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00125-015-3808-0","article-title":"Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients","volume":"59","author":"Favaro","year":"2016","journal-title":"Diabetologia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"24120","DOI":"10.1038\/srep24120","article-title":"Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions","volume":"6","author":"Di Trapani","year":"2016","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","article-title":"MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis","volume":"8","author":"Shigemoto-Kuroda","year":"2017","journal-title":"Stem Cell Reports"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1038\/s41598-017-04559-y","article-title":"Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis","volume":"7","author":"Bai","year":"2017","journal-title":"Sci Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","article-title":"Immune regulatory cell infusion for graft-vs. -host disease prevention and therapy","volume":"131","author":"Blazar","year":"2018","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/stem.2759","article-title":"Graft-vs. -host disease amelioration by human bone marrow mesenchymal stromal\/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations","volume":"36","author":"Fujii","year":"2018","journal-title":"Stem Cells"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/stem.1934","article-title":"Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo","volume":"33","author":"Amarnath","year":"2015","journal-title":"Stem Cells"},{"key":"B81","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtm.2019.01.001","article-title":"Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs","volume":"13","author":"Pomatto","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1182\/blood-2011-10-387522","article-title":"Regulation of acute graft-vs. -host disease by microRNA-155","volume":"119","author":"Ranganathan","year":"2012","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fimmu.2018.00992","article-title":"MicroRNA in T-cell development and T-cell mediated acute graft-vs. -host disease","volume":"9","author":"Koenecke","year":"2018","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.4049\/jimmunol.1701465","article-title":"MicroRNA-155 modulates acute graft-vs. -host disease by impacting T cell expansion, migration, and effector function","volume":"200","author":"Zitzer","year":"2018","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"23360","DOI":"10.18632\/oncotarget.15579","article-title":"Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-vs. -host disease following allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"B86","doi-asserted-by":"publisher","first-page":"38339","DOI":"10.1038\/srep38339","article-title":"miR-146a-mediated suppression of the inflammatory response in human adipocytes","volume":"6","author":"Roos","year":"2016","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","first-page":"10299","DOI":"10.1038\/s41598-019-44743-w","article-title":"Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation","volume":"9","author":"Balducci","year":"2019","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1182\/bloodadvances.2017008375","article-title":"The use of defibrotide in blood and marrow transplantation","volume":"2","author":"Richardson","year":"2018","journal-title":"Blood Adv"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"B90","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.leukres.2011.08.005","article-title":"Elevated Fas\/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-vs. -host disease: a clinical analysis","volume":"36","author":"Wu","year":"2012","journal-title":"Leuk Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/leu.2017.277","article-title":"Extracellular vesicles as potential biomarkers of acute graft-vs-host disease","volume":"32","author":"Lia","year":"2018","journal-title":"Leukemia"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1016\/j.bbmt.2018.12.223","article-title":"Biomarkers of acute graft-vs. -host disease: surface antigens and micro rnas in extracellular vesicles","volume":"25","author":"Brunello","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2017.01446","article-title":"Serum and extracellular vesicle micrornas miR-423, miR-199, and miR-93* as biomarkers for acute graft-vs. -host disease","volume":"8","author":"Crossland","year":"2017","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.leu.2404132","article-title":"Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1182\/blood-2014-01-547927","article-title":"Shear enhances thrombopoiesis and formation of microparticles that induce megakaryocytic differentiation of stem cells","volume":"124","author":"Jiang","year":"2014","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.18632\/oncotarget.6791","article-title":"MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation","volume":"7","author":"De Luca","year":"2016","journal-title":"Oncotarget"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/stem.3032","article-title":"The incorporation of extracellular vesicles from mesenchymal stromal cells into CD34 + Cells increases their clonogenic capacity and bone marrow lodging ability","volume":"37","author":"Preciado","year":"2019","journal-title":"Stem Cells."},{"key":"B98","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4161\/jkst.20006","article-title":"STAT signaling in the pathogenesis and treatment of myeloid malignancies","volume":"1","author":"Bar-Natan","year":"2012","journal-title":"JAKSTAT"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/leu.2016.107","article-title":"Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells","volume":"30","author":"Wen","year":"2016","journal-title":"Leukemia"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1002\/stem.2716","article-title":"Mesenchymal stromal cell-derived extracellular vesicles provide long-term survival after total body irradiation without additional hematopoietic stem cell support","volume":"35","author":"Schoefinius","year":"2017","journal-title":"Stem Cells"},{"key":"B101","doi-asserted-by":"publisher","first-page":"717","DOI":"10.4049\/jimmunol.1401250","article-title":"HY-Specific induced regulatory T cells display high specificity and efficacy in the prevention of acute graft-vs. -host disease","volume":"195","author":"Li","year":"2015","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4049\/jimmunol.1201641","article-title":"Unraveling graft-vs. -host disease and graft-vs. -leukemia responses using TCR V\u03b2 spectratype analysis in a murine bone marrow transplantation model","volume":"190","author":"Fanning","year":"2013","journal-title":"J Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/eji.201747177","article-title":"IL-12\/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation","volume":"48","author":"Song","year":"2018","journal-title":"Eur J Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.3389\/fimmu.2018.03041","article-title":"Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-vs. -host disease","volume":"9","author":"Chang","year":"2018","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3389\/fimmu.2019.01205","article-title":"Cancer immunotherapy based on natural killer cells: current progress and new opportunities","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1294368","DOI":"10.1080\/20013078.2017.1294368","article-title":"Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells","volume":"6","author":"Jong","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.4049\/jimmunol.1101988","article-title":"Immune surveillance properties of human NK cell-derived exosomes","volume":"189","author":"Lugini","year":"2012","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3389\/fimmu.2018.01534","article-title":"Therapeutic prospects of extracellular vesicles in cancer treatment","volume":"9","author":"Chulpanova","year":"2018","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1588538","DOI":"10.1080\/20013078.2019.1588538","article-title":"Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells","volume":"8","author":"Wu","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fphar.2019.01152","article-title":"Immunotherapy based on dendritic cell-targeted\/-derived extracellular vesicles-a novel strategy for enhancement of the anti-tumor immune response","volume":"10","author":"Markov","year":"2019","journal-title":"Front Pharmacol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e0138335","DOI":"10.1371\/journal.pone.0138335","article-title":"Rapamycin promotes mouse 4T1 tumor metastasis that can be reversed by a dendritic cell-based vaccine","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS ONE"},{"key":"B112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.32607\/20758251-2017-9-3-27-38","article-title":"Antitumor vaccines based on dendritic cells: from experiments using animal tumor models to clinical trials","volume":"9","author":"Markov","year":"2017","journal-title":"Acta Naturae."},{"key":"B113","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2217\/imt-2018-0103","article-title":"Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model","volume":"11","author":"Liu","year":"2019","journal-title":"Immunotherapy"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4161\/onci.20897","article-title":"Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands","volume":"1","author":"Munich","year":"2012","journal-title":"Oncoimmunology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.1007\/s13277-015-3741-3","article-title":"High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders","volume":"36","author":"Caivano","year":"2015","journal-title":"Tumor Biol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1080\/10428194.2016.1243790","article-title":"Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia","volume":"58","author":"De Luca","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"B117","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fimmu.2014.00160","article-title":"Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia","volume":"5","author":"Hong","year":"2014","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1021\/acsnano.5b08015","article-title":"Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine","volume":"10","author":"Fais","year":"2016","journal-title":"ACS Nano"},{"key":"B119","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/bjh.13551","article-title":"Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance","volume":"172","author":"Viola","year":"2016","journal-title":"Br J Haematol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.21873\/anticanres.12679","article-title":"The potential of exosomes derived from chronic myelogenous leukaemia cells as a biomarker","volume":"38","author":"Kang","year":"2018","journal-title":"Anticancer Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.18632\/oncotarget.2159","article-title":"Multiple myeloma cell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation","volume":"5","author":"Arendt","year":"2014","journal-title":"Oncotarget"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","article-title":"Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8+ CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70","volume":"14","author":"Xie","year":"2010","journal-title":"J Cell Mol Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neo.2015.11.011","article-title":"Isolation of human CD138+ microparticles from the plasma of patients with multiple myeloma","volume":"18","author":"Krishnan","year":"2016","journal-title":"Neoplasia"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e103310","DOI":"10.1371\/journal.pone.0103310","article-title":"Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia","volume":"9","author":"Hong","year":"2014","journal-title":"PLoS ONE"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3324\/haematol.2010.039743","article-title":"Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1","volume":"96","author":"Szczepanski","year":"2011","journal-title":"Haematologica"},{"key":"B126","first-page":"1815","article-title":"Focus on exosomes: novel pathogenic components of leukemia","volume":"9","author":"Yang","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13402-016-0300-x","article-title":"MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report","volume":"40","author":"Caivano","year":"2017","journal-title":"Cell Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3727\/096368911X582769","article-title":"Stem cell transplantation in amyotrophic lateral sclerosis patients: methodological approach, safety, and feasibility","volume":"21","author":"Mart\u00ednez","year":"2012","journal-title":"Cell Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T15:36:58Z","timestamp":1584718618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":128,"alternative-id":["10.3389\/fimmu.2020.00422"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00422","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]},"article-number":"422"}}